KIORA PHARMACEUTICALS, INC. Deferred Income Tax Liabilities, Net
KIORA PHARMACEUTICALS, INC. (KPRX) had Deferred Income Tax Liabilities, Net of $102.15 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-07
- 2026-06-30: Deferred Income Tax Liabilities, Net $102.15K.
- 2026-03-31: Deferred Income Tax Liabilities, Net $102.15K.
- 2025-12-31: Deferred Income Tax Liabilities, Net $102.15K.
- 2025-09-30: Deferred Income Tax Liabilities, Net $490.69K.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2026-06-30 | $102.15K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $102.15K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $102.15K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $490.69K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $490.69K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $490.69K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $490.69K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $779.44K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $779.44K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $779.44K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $779.44K 10-K · filed 2025-03-25 | |
| 2023-09-30 | $689.12K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $689.12K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $689.12K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $689.12K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $802.13K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $802.13K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $802.13K 10-Q · filed 2022-07-08 | |
| 2021-12-31 | $802.13K 10-K · filed 2023-03-23 | $614.44K 10-K · filed 2022-04-15 |
| 2021-09-30 | $728.93K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $728.93K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $728.93K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $728.93K 10-K/A · filed 2022-07-07 | |
| 2020-09-30 | $365.36K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $365.36K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $365.36K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $365.36K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $269.97K 10-Q · filed 2019-11-07 | |
| 2018-12-31 | $269.97K 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |